Literature DB >> 15906086

Loss of intrahepatic bile ducts: an important feature of familial hemophagocytic lymphohistiocytosis.

Klaus Kapelari1, Martin Fruehwirth, Andreas Heitger, Alfred Königsrainer, Raimund Margreiter, Burkhard Simma, Felix Albert Offner.   

Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is a rare, fatal disorder of early infancy. We report two siblings with FHL whose symptoms were dominated by hepatic failure. Both presented with sudden-onset fever and hepatosplenomegaly with progressive abnormalities of clinical biochemistry indices of liver function. One died of hepatorenal failure. The other underwent liver transplantation. Autopsy and explant liver displayed portal and periportal infiltrates of T lymphocytes and histiocytes; an activation of the hepatic mononuclear phagocytic system with focal hemophagocytosis; and almost complete loss of interlobular bile ducts. Paucity of bile ducts dominated in a pre-transplant liver biopsy specimen (and transiently obscured the diagnosis of FHL). Disease recurred in the allograft, again with lymphohistiocytic infiltration and destruction of interlobular bile ducts. Consequently the patient underwent haploidentical peripheral stem cell transplantation. This patient is alive 5 years later. Loss of bile ducts may be an important feature of hepatic involvement by FHL.

Entities:  

Mesh:

Year:  2005        PMID: 15906086     DOI: 10.1007/s00428-005-1238-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

1.  Familial haemophagocytic reticulosis.

Authors:  J W FARQUHAR; A E CLAIREAUX
Journal:  Arch Dis Child       Date:  1952-12       Impact factor: 3.791

2.  Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis.

Authors:  A Ost; S Nilsson-Ardnor; J I Henter
Journal:  Histopathology       Date:  1998-04       Impact factor: 5.087

3.  The role of infections in primary hemophagocytic lymphohistiocytosis: a case series and review of the literature.

Authors:  L Sung; S S Weitzman; M Petric; S M King
Journal:  Clin Infect Dis       Date:  2001-10-05       Impact factor: 9.079

Review 4.  Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis.

Authors:  Gael Ménasché; Jérôme Feldmann; Alain Fischer; Geneviève de Saint Basile
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

5.  Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis.

Authors:  M Parizhskaya; J Reyes; R Jaffe
Journal:  Pediatr Dev Pathol       Date:  1999 Jul-Aug

6.  Histopathology of the liver in histiocytosis syndromes.

Authors:  B E Favara
Journal:  Pediatr Pathol Lab Med       Date:  1996 May-Jun

7.  Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases.

Authors:  S Imashuku; S Hibi; M Sako; T Ishii; U Kohdera; K Kitazawa; K Ooe; M Naya; H Sawada; T Kawakami
Journal:  J Pediatr Hematol Oncol       Date:  1998 May-Jun       Impact factor: 1.289

8.  Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene.

Authors:  M Arico; S Imashuku; R Clementi; S Hibi; T Teramura; C Danesino; D A Haber; K E Nichols
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

9.  Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis.

Authors:  R Clementi; U zur Stadt; G Savoldi; S Varoitto; V Conter; C De Fusco; L D Notarangelo; M Schneider; C Klersy; G Janka; C Danesino; M Aricò
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

Review 10.  Pathogenesis of haemophagocytic lymphohistiocytosis.

Authors:  M Aricò; C Danesino; D Pende; L Moretta
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

View more
  1 in total

Review 1.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  Gritta E Janka
Journal:  Eur J Pediatr       Date:  2006-12-07       Impact factor: 3.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.